Crdl stock forecast.

Previous Close $0.8. Volume 30.98K. Average Volume (3M) 87.47K. Market Cap. $8.73M. Enterprise Value $15.67M. Total Cash (Recent Filing) $653.19K. Total Debt (Recent Filing) $7.60M. Price to Earnings (P/E) -0.6.WebAnalyst Forecast. According to 2 analysts, the average rating for CRDL stock is "Strong Buy." The 12-month stock price forecast is $4.5, which is an increase …Aug 15, 2023 · Cardiol Therapeutics (CRDL) will release its next earnings report on Aug 15, 2023. In the last quarter Cardiol Therapeutics reported -$0.082 EPS in relation to -$0.082 expected by the market. Promising Performance and Positive Forecasts: CRDL Stock Shows Potential Increase in Value. CRDL stock had a promising performance on September 19, 2023, based on the information provided by CNN Money. The stock received positive forecasts from analysts, indicating a potential increase in value. According to the data, …WebNasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be posted from 4:15 p ...

Cardiol Therapeutics is a clinical-stage life sciences company that develops anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease. The company's lead product CardiolRx is in Phase II/III study for COVID-19 and heart failure. …

Cardiol Therapeutics Inc Class A Price (CRDL) Daily Price Prediction Charts3 brokerages have issued 1-year price targets for NuScale Power's shares. Their SMR share price targets range from $7.50 to $14.50. On average, they expect the company's stock price to reach $11.33 in the next twelve months. This suggests a possible upside of 310.6% from the stock's current price.

Their GOSS share price targets range from $1.25 to $10.00. On average, they predict the company's stock price to reach $5.58 in the next twelve months. This suggests a possible upside of 674.6% from the stock's current price. View analysts price targets for GOSS or view top-rated stocks among Wall Street analysts.WebAug 15, 2023 · Cardiol Therapeutics (CRDL) will release its next earnings report on Aug 15, 2023. In the last quarter Cardiol Therapeutics reported -$0.082 EPS in relation to -$0.082 expected by the market. 52 Week Low Date 04/06/23. Market Cap 63.52M. Shares Out 64.13M. 10 Day Average Volume 0.14M. Dividend -. Dividend Yield -. Beta -. YTD % Change 107.84.WebNov 22, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) issued its earnings results on Monday, November, 15th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.09. The firm earned $6.12 million during the quarter. Forecast . Price target. 5.88 0.00 0.00%. The 3 analysts offering 1 year price forecasts for CRDL have a max estimate of — and a min estimate of —. Analyst rating. Based on 3 analysts giving stock ratings to CRDL in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreWeb

Aug 15, 2023 · Cardiol Therapeutics (CRDL) will release its next earnings report on Aug 15, 2023. In the last quarter Cardiol Therapeutics reported -$0.082 EPS in relation to -$0.082 expected by the market.

Robinhood Markets Stock Forecast 12-02-2023. Forecast target price for 12-02-2023: $ 8.99. Negative dynamics for Robinhood Markets shares will prevail with possible volatility of 4.496%. Pessimistic target level: 8.86. Optimistic target level: 9.28.Web

The 3 analysts offering 1 year price forecasts for CRDL have a max estimate of — and a min estimate of —. Analyst rating Based on 3 analysts giving stock ratings to CRDL in …Find the latest Corvus Pharmaceuticals, Inc. (CRVS) stock quote, history, news and other vital information to help you with your stock trading and investing.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Current price models forecast CRDL shares to reach between $2.21 and $6.00, with the median target at $3.47, 328% higher than its current price. The bullish appraisals share a common theme, which ...Find the latest Viking Therapeutics, Inc. (VKTX) stock quote, history, news and other vital information to help you with your stock trading and investing.London Stock Forecast . London Stock Exchange Stock Forecast LSE Share Price Predictions with Smart Prognosis Chart - 2023-2024 ...

Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Aenza S.A.A. saw a decrease in short interest in October. As of October 31st, there was short interest totaling 11,100 shares, a decrease of 6.7% from the October 15th total of 11,900 shares. Based on an average daily trading volume, of 9,200 shares, the days-to-cover ratio is presently 1.2 days.Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...How have CRDL shares performed in 2023? Cordel Group's stock was trading at GBX 6.25 on January 1st, 2023. Since then, CRDL shares have decreased by 17.6% and is now trading at GBX 5.15. View the best growth stocks for 2023 here.Advanced Micro Devices Inc () Stock Market info Recommendations: Buy or sell Advanced Micro Devices stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Advanced Micro Devices share forecasts, stock quote and buy / sell signals below.According to present data Advanced Micro Devices's AMD shares and potentially …WebIs Cardiol Therapeutics Stock Undervalued? The current Cardiol Therapeutics share price is $1.02. The Score for CRDL.TO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal. CRDL.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.WebView research reports from Argus and trade ideas from Trading Central to understand future stock performances and find high performing trade ideas.

Alpine’s stock has gained 62.3% so far this year. In the past 60 days, estimates for Alpine’s 2023 loss per share have narrowed from $1.43 to $1.18, while those for 2024 have improved from a ...

Nov 30, 2023 · It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ... The most active stock market forums in the UK. Cordel share chat. The most active stock market forums in the UK. ... CRDL: London: Ordinary Share: GB00BYZQM590: ORD 1P Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade : 0.00: 0.0%: 5.05: ... any financial information that might …The average Cardiol Therapeutics stock price prediction forecasts a potential upside of 237.08% from the current CRDL share price of $0.89. What is CRDL's forecast return on equity (ROE) for 2023-2026?Find real-time AEVA - Aeva Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.WINS.VN : 0.280 (unch) Winshear Gold Closes Oversubscribed $750,000 Private Placement Globe Newswire - Wed Dec 1, 2021. NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 01, 2021 (GLOBE... WINS.VN : 0.280 (unch) …Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.The average Tesla stock price prediction forecasts a potential downside of 0.48% from the current TSLA share price of $246.72. What is TSLA's forecast return on equity (ROE) for 2023-2025? (NASDAQ: TSLA) forecast ROE is 37.04%, which is considered strong.WebNov 22, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) issued its earnings results on Monday, November, 15th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.09. The firm earned $6.12 million during the quarter. Alpine’s stock has gained 62.3% so far this year. In the past 60 days, estimates for Alpine’s 2023 loss per share have narrowed from $1.43 to $1.18, while those for 2024 have improved from a ...

Broker Zeus forecasts that revenue will increase by more than 50% in FY24 driven by continuing and new contracts, with a gross margin maintained at c. 75% and persisting losses due to £1.2m of planned investment in new hires to support medium-term growth. ... Stock Chart | CRDL. Follow News & Updates from Cordel Group: Follow | CRDL. 0. …

London Stock Forecast . London Stock Exchange Stock Forecast LSE Share Price Predictions with Smart Prognosis Chart - 2023-2024 ...

Cardiol Therapeutics Inc Follow Share $0.81 After Hours: $0.85 (3.92%) +0.032 Closed: Nov 22, 5:42:11 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Cronos Group Inc $2.00 CRON1.48% Clever...The latest Cardiol Therapeutics stock prices, stock quotes, news, and CRDL history to help you invest and trade smarter. ... The 4 analysts offering price forecasts for Cardiol Therapeutics have a ...Nov 24, 2023 · 2 Wall Street analysts have issued twelve-month price targets for Context Therapeutics' shares. Their CNTX share price targets range from $4.00 to $5.00. On average, they predict the company's share price to reach $4.50 in the next year. This suggests a possible upside of 419.6% from the stock's current price. Nov 29, 2023 · According to the issued ratings of 5 analysts in the last year, the consensus rating for Aeva Technologies stock is Moderate Buy based on the current 2 hold ratings and 3 buy ratings for AEVA. The average twelve-month price prediction for Aeva Technologies is $1.62 with a high price target of $2.00 and a low price target of $0.96. Nov 29, 2023 · 3 brokerages have issued 1-year price targets for NuScale Power's shares. Their SMR share price targets range from $7.50 to $14.50. On average, they expect the company's stock price to reach $11.33 in the next twelve months. This suggests a possible upside of 310.6% from the stock's current price. Forecast data have also been adjusted to remove the effect of business rates 100 per cent retention pilots, which reduce DEL and increase local authority self-financed expenditure by equal and offsetting amounts. Spending measured in cash terms is a simple metric for analysing trends over time. But without putting the cash amount into …2 days ago · View Cardiol Therapeutics Inc CRDL investment & stock information. Get the latest Cardiol Therapeutics Inc CRDL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Stock analysis for Cardiol Therapeutics Inc (CRDL:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.9 equities research analysts have issued 12 month price objectives for Lucid Group's stock. Their LCID share price targets range from $4.00 to $8.00. On average, they anticipate the company's stock price to reach $5.94 in the next year. This suggests a possible upside of 37.9% from the stock's current price.Cardiol Therapeutics is forecast to grow earnings and revenue by 34% and 84.7% per annum respectively while EPS is expected to grow by 35.4% per annum. CRDL stock opened at $0.86 on Friday. The stock’s fifty day simple moving average is $0.84 and its two-hundred day simple moving average is $0.86. Cardiol Therapeutics Inc. has a 1-year low of $0.45 and a 1-year high of $1.24. The stock has a market cap of $55.91 million, a P/E ratio of -2.61 and a beta of 0.50.Web24.07%. Get the latest Cardiol Therapeutics Inc (CRDL) real-time quote, historical performance, charts, and other financial information to help you make more informed …

Get the latest information on Cardiol Therapeutics Inc. (CRDL), a clinical-stage life sciences company that develops anti-inflammatory and anti-fibrotic therapies for heart disease. See the stock quote, performance outlook, news, research reports and more on Yahoo Finance. View the latest Cardiol Therapeutics Inc. (CRDL) stock price, news, historical charts, analyst ratings and financial information from WSJ. The average Cardiol Therapeutics stock price prediction forecasts a potential upside of 237.08% from the current CRDL share price of $0.89. What is CRDL's forecast return on equity (ROE) for 2023-2026?Instagram:https://instagram. csco newshow to sell robinhood stockpenny stocks to day tradehow to buy indian stocks The average Amazon stock price prediction forecasts a potential upside of 17.34% from the current AMZN share price of $147.03. What is AMZN's forecast return on equity (ROE) for 2023-2026? (NASDAQ: AMZN) forecast ROE is N/A, which is considered weak.Find the latest Corvus Pharmaceuticals, Inc. (CRVS) stock quote, history, news and other vital information to help you with your stock trading and investing. federated hermes treasury obligations fundwhat is nvda Cardiol Therapeutics (CRDL) Earnings Date, Estimates & Call Transcripts $0.93 +0.01 (+1.09%) (As of 12/1/2023 ET) Compare Today's Range $0.91 $0.93 50-Day …Nov 25, 2023 · Cardiol Therapeutics Stock Forecast 2023. In the last five quarters, Cardiol Therapeutics’s Price Target has risen from C$0.00 to C$1.20 - a 100% increase. 0 analysts predict that Cardiol Therapeutics’s share price will increase in the coming year, reaching C$4.50. This would represent an increase of 275%. stock price canopy The average Solid Power stock price prediction forecasts a potential upside of 136.38% from the current SLDP share price of $1.41. What is SLDP's forecast return on equity (ROE) for 2023-2026? (NASDAQ: SLDP) forecast ROE is N/A, which is considered weak.Web2 Wall Street analysts have issued twelve-month price targets for Context Therapeutics' shares. Their CNTX share price targets range from $4.00 to $5.00. On average, they predict the company's share price to reach $4.50 in the next year. This suggests a possible upside of 419.6% from the stock's current price.